医学
血小板生成素
美罗华
血小板
免疫性血小板减少症
血小板生成素受体
罗米普洛斯蒂姆
埃尔特罗姆博帕格
免疫系统
抗体
免疫学
内科学
胃肠病学
造血
干细胞
生物
遗传学
作者
Nichola Cooper,Waleed Ghanima
标识
DOI:10.1056/nejmcp1810479
摘要
Immune thrombocytopenia in patients who present with serious bleeding is treated with platelet transfusions, glucocorticoids, and intravenous immune globulin. In patients without serious bleeding, treatment decisions are guided by the platelet count and other factors. Commonly used agents include glucocorticoids, thrombopoietin-receptor agonists, and rituximab.
科研通智能强力驱动
Strongly Powered by AbleSci AI